Ulipristal acetate | Esmya® | moderate to severe symptoms of uterine... | 6>4>1 | BLACK | MHRA MArch 2020 - LICENSE SUSPENDED |
Ulipristal acetate 5mg | Esmya® | Pre-operative treatment of uterine... | 6>4>1 | RED | To be used in line with MHRA guidance... |
Umeclidinium | Incruse®▼ | COPD | Black Traffic Light | BLACK | |
Umeclidinium with vilanterol | Anoro Ellipta dpi | COPD | 3>2 | AMBER | To offer consistency of device for... |
Universal fit insulin pen needles | Insupen, GlucoRX finepoint, Omnican... | Insulin Pen needles | 6>1>6 | GREEN | |
Upadactinib | Rinvoq | Severe rheumatoid arthritis NICE TA665 | 10>1>3 | RED | CCG Commissioned - Blueteq form... |
Upadactinib | Rinvoq | Moderate active rheumatoid arthritis -... | 10>1>3 | RED | CCG Commissioned Blueteq form required |
Upadactinib | Rinvoq | Active psoriatic arthritis in adults:... | 10>1>3 | RED | CCG Commissioned Blueteq form required |
Upadactinib | Rinvoq | Moderate to severe atopic dermatitis -... | 13>5>3 | RED | ICB Commissioned [Formerly CCG] |
Upadactinib | Rinvoq | Active ankylosing spondylitis that is... | 10>1>3 | RED | NHS England Commissioned |
Upadactinib | Rinvoq | Moderately to severely active... | 1>5>1 | RED | ICS Commissioned , Blueteq form... |
Upadactinib | Rinvoq | Active non-radiographic axial... | 10>1>3 | RED | ICS Commissioned , Blueteq form... |
Upadactinib | Rinvoq | Previously treated moderately to... | 1>5 | RED | ICB Commissioned Blueteq form required |
Urea 10% cream | Flexitol® cream | Emollient (containing urea) | 13>2>1 | GREEN | |
Urea 25% Heel Balm | Flexitol® Heel Balm cream | Treatment of dry skin on the heels and... | 13>2 | GREEN | For use in Diabetic Patients only |
Urokinase | Syner-KINASE® | Antifibrinolytic | 2>10>2 | RED | |
Ursodeoxycholic acid | Destolit® Urdox® ... | Dissolution of gallstones, primary... | 1>9>1 | AMBER | |
Ustekinumab | Stelara® | Plaque psoriasis in children and young... | 13>5>3 | RED | NHS England commissioned |
Ustekinumab | Stelara® | Moderate to severe plaque psoriasis... | 13>5>3 | RED | CCG Commissioned |
Ustekinumab | Stelara® | Moderately to severely active... | 1>5>3 | RED | CCG Commissioned |